Back to News
Feb 17, 2026 4:11 PM

Halozyme Therapeutics Earnings Report: Q4 Overview

Halozyme Therapeutics (NASDAQ:HALO) released its Q4 earnings on Tuesday, February 17, 2026 at 04:01 PM.

Here's what's important from the earnings announcement.

Earnings

Halozyme Therapeutics missed estimated earnings by -111.16%, reporting an EPS of $-0.24 versus an estimate of $2.15.

Revenue was up $153.76 million from the same period last year.

Earnings History Overview

During the previous quarter, the company beat on EPS by $0.14, leading to a 2.79% increase share price change ...